Navigation Links
Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer
Date:12/7/2011

er the most common oncogenic driver is estrogen receptor signaling.  Blocking estrogen activity with aromatase inhibitors represents an effective treatment for most ER+ MBC patients, however acquired drug resistance to aromatase inhibitors leads to disease progression, ultimately requiring less effective, more toxic chemotherapies.(1)  Delaying resistance and disease progression represents a significant unmet need that could prolong survival while decreasing health care costs associated with chemotherapy and hospitalization.

About Entinostat
Syndax's lead product entinostat is a novel, oral small molecule inhibitor of class I histone deacetylases, key enzymes that alter the structure of chromatin to control gene expression. Entinostat is differentiated from other members of the class through its unique selectivity profile, pharmacokinetic properties and safety profile. Entinostat has been studied in more than 600 cancer patients where objective tumor responses have been observed in both solid and hematologic malignancies.  Breast cancer animal models demonstrated that resistance to aromatase inhibitors occurs through up-regulation of growth factor signaling pathways and down-regulation of estrogen receptor-alpha (ERα). Entinostat effectively down-regulates growth factor signaling in breast cancer cells where these pathways are active. Entinostat also up-regulates the expression of ER in breast cancer cells which have negligible or undetectable levels of ER. The ability to target multiple mechanisms of resistance establishes entinostat as a promising candidate for preventing and overcoming aromatase inhibitor resistance through epigenetic modulation. In pre-clinical testing entinostat induced tumor regression when combined with an aromatase inhibitor after the development of hormone resistance.

Additional phase 2
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
2. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
3. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
4. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
5. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
6. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
7. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
8. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
9. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
10. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
11. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Medical Tracking Solutions, Inc., developers of ... Brian Timberlake as Senior Vice President ... build relationships with existing and new clients. Brian brings ... and sales management as well as a deep ... comprehensive inventory management system that provides real-time tracking ...
(Date:3/3/2015)... Tenn., March 3, 2015  Cumberland Pharmaceuticals Inc. (NASDAQ: ... focused on hospital acute care and gastroenterology, today ... The Company,s revenue grew 15% in 2014 to ... million or $0.35 per diluted share. At the ... over $95 million including $55 million in cash ...
(Date:3/3/2015)...  This industry report package offers the most up-to-date market data on ... the world and in the top 10 global countries. Along with a ... following countries: Australia , China ... Italy , Japan , ... , United States The reports ...
Breaking Medicine Technology:Medical Tracking Solutions, Inc. Hires New SVP, Sales 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 3Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 4Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 5Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 6Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 7Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 8Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 9Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 11Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 12Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 13Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 14Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 15Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 16Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 17Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 18Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2
... ("ClearChoice"), a market leading developer and manager of ... dental implant care, today announced a growth equity ... consumer-focused private equity firm. The investment will be ... expansion plan to double the number of ClearChoice affiliated ...
... Reportlinker.com announces that a new ... its catalogue: Healthcare ... 2016 - Hospital Information Systems and ... http://www.reportlinker.com/p0259649/Healthcare-IT-Market-Outlook-in- Sweden-to-2016---Hospital-Information-Systems-and-Medical-Imaging-Information-Systems.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=IT_Services ...
Cached Medicine Technology:ClearChoice Receives Investment From Leading Consumer Private Equity Firm Catterton Partners 2ClearChoice Receives Investment From Leading Consumer Private Equity Firm Catterton Partners 3ClearChoice Receives Investment From Leading Consumer Private Equity Firm Catterton Partners 4Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Systems and Medical Imaging Information Systems 2Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Systems and Medical Imaging Information Systems 3Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Systems and Medical Imaging Information Systems 4Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Systems and Medical Imaging Information Systems 5Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Systems and Medical Imaging Information Systems 6Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Systems and Medical Imaging Information Systems 7
(Date:3/4/2015)... 04, 2015 A new poll by ... When asked —“What retirement cost is hardest for you ... and prescription costs were most difficult, 40% — as ... Sixteen percent said nourishing food, and 4% said ... is important because it illustrates the significance of healthcare ...
(Date:3/4/2015)... Theme and plugin developers from Pixel ... Final Cut Pro X entitled ProFont NoteBook , “ProFont NoteBook ... FCPX editors project.” Said Christiana Austin, CEO of Pixel Film ... animated font to their FCPX media.” , With ProFont Notebook ... Final Cut Pro X. ProFont Notebook offers users up to ...
(Date:3/4/2015)... Chicago (PRWEB) March 04, 2015 Professionals ... want more targeted outreach from companies, according to a ... December 2014 survey of 235 professionals with disabilities ... more online job search tools, including ones that are ... meaningful work. Some highlights:, ,     Online job ...
(Date:3/4/2015)... 2015 The medical device landscape is ... forgot – or ignored or didn't know – the ... based on physician input before proceeding to design and ... founders – become so enamored of an innovative concept ... physicians use the device?” says Dr. Kathryn Stecco ...
(Date:3/3/2015)... Anik Singal's Profit Academy - ... marketers has become the talk of the town ... surrounding the course's general release has garnered the ... her to review the program's content and publish ... biggest keys to success with Internet marketing is ...
Breaking Medicine News(10 mins):Health News:Most Difficult Cost In Retirement? Retirees Evenly Split Between Housing and Healthcare, Says New Poll By The Senior Citizens League 2Health News:Announcing a New Title Pack from Pixel Film Studios, ProFont NoteBook for Final Cut Pro X 2Health News:Job Seekers with Disabilities Seek Targeted Outreach from Employers and Online Job Search Tools, says New Think Beyond The Label Survey 2Health News:Job Seekers with Disabilities Seek Targeted Outreach from Employers and Online Job Search Tools, says New Think Beyond The Label Survey 3Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2
... A Bengali teenager, who won his battle with cancer, is ... story of his recovery from the deadly ailment. ... School in Siliguri, about 600 km from the state capital, ... with the financial support of cricketer Sourav Ganguly and his ...
... a unique feature. In addition to the attendance roster kept ... the students. ,This ingenious book keeps track ... been clipped, clothes are clean, hair is properly cut and ... and before eating. ,Schools have been identified as ...
... and ticking like a well-oiled machine, all you have to ... ,The finding is based on a new research ... and Michael J. Sheridan, Sc.D., of Inova Fairfax Hospital, who ... heart healthy fat, improves risk factors for heart disease with ...
... lead character smokes is not as effective a method as ... the appeal of smoking to , are non-smokers. ... the June issue of the journal Tobacco Control. ... whom were current smokers, aged 12-24 years in Australia, over ...
... through an entire life without contributing a huge amount to ... carbon footprint jumps . Alarmed by the fuel-intensive nature of ... firewood, an environmental group in New Delhi is promoting a ... we must do our last rites in this way," said ...
... out of the sun, especially in the initial stages of ... are more sensitive to high temperatures . ,The ... on the findings of a new study carried out by ... ,In this study, the researchers found that exposure to ...
Cached Medicine News:Health News:Where Children Lead the Sanitation Drive 2Health News:Where Children Lead the Sanitation Drive 3Health News:A Handful of Pistachios a Day Helps to Keep Your Heart Healthy 2Health News:New 'green' Pyre to Cool Planet While Burning India's Dead 2Health News:New 'green' Pyre to Cool Planet While Burning India's Dead 3
The Guidant Fineline leads are bipolar endocardial and designed for permanent implantation with pulse generators for cardiac pacing....
Steroid-eluting, screw-in pacing lead...
... Guidant Flextend lead is ... lead with an extendable/retractable ... helix design offers various ... permanent implantation in the ...
The Vitatron Brilliant S+ lead series are endocardial leads designed for the Vitatron VDD pacemaker systems offering optimal atrial sensing, superior handling and excellent pacing characteristics....
Medicine Products: